PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced that it has received marketing authorization for Plenaxis(R) (abarelix 100 mg...
PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced that it presented preclinical data on its investigational compound, PPI-2458...
PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced consolidated financial results for the three and six months ended June 30...
PRAECIS PHARMACEUTICALS INCORPORATED (NASDAQ: PRCS) today announced consolidated financial results for the three months ended March 31, 2005. ?...
Schatz & Nobel, P.C. Announces Class Action Lawsuit Against Praecis Pharmaceuticals Inc. HARTFORD, Conn., Dec. 9 /PRNewswire/ -- The law firm of...
Shareholder Class Action Filed Against Praecis Pharmaceuticals Inc. By The Law Firm of Schiffrin & Barroway, LLP BALA CYNWYD, Pa., Dec. 9...
American Stock Exchange to Trade Options on Seven Securities NEW YORK, Dec. 19 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.